Glucose, lipid, and blood pressure control in Australian adults with type 2 diabetes: The 1999-2000 AusDiab

Diabetes Care

Volumn 28, Issue 6, 2005, Pages 1490-1492

  Kemp, Thomas M ^a   Barr, Elizabeth L M ^b   Zimmet, Paul Z ^b   Cameron, Adrian J ^b   Welborn, Timothy A ^c   Colagiuri, Stephen ^d   Phillips, Patrick ^e   Shaw, Jonathan E ^b  

^a Dewsbury and District Hospital ^*  (United Kingdom)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d PRINCE OF WALES HOSPITAL   (Australia)

^e QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC DIET; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; INSULIN TREATMENT; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AUSTRALIA; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HEALTH SURVEYS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LIPIDS;

EID: 19944387957     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.6.1490     Document Type: Article

References (19)

1. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
2. Collins R, Armitage J, Parish S, Sleight P, Peto R: MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361: 2005-2016, 2003
3. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S, the HOT Study Group: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351:1755-1762, 1998
4. UK Prospective Diabetes Study (UKPDS) Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317:703-713, 1998
5. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS: Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care 22:403-408, 1999
6. Saydah SH, Fradkin J, Cowie CC: Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291:335-342, 2004
7. 1c in an unselected population of 4438 people with type 2 diabetes in a Danish county. Scand J Prim Health Care 19:241-246, 2001
8. Beaton SJ, Nag SS, Gunter MJ, Gleeson JM, Sajjan SS, Alexander CM: Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting. Diabetes Care 27: 694-698, 2004
9. Phillips P, Wilson D, Beilby J, Taylor A, Rosenfeld E, Hill W, Parsons J: Diabetes complications and risk factors in an Australian population: how well are they managed? Int J Epidemiol 27:853-859, 1998
10. Dunstan DW, Zimmet PZ, Welborn TA, Cameron AJ, Shaw JE, deCourten M, Jolley D, McCarty DJ, the AusDiab Steering Committee: The Australian Diabetes, Obesity and Lifestyle Study (AusDiab): methods and response rates. Diabetes Res Clin Pract 57:119-129, 2002
11. World Health Organization: Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, Department of Noncommunicable Disease Surveillance, 1999
12. Briganti EM, Shaw JE, Chadban SJ, Zimmet PZ, Welborn TA, McNeil JJ, Atkins RC: Untreated hypertension among Australian adults: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust 179:135-139, 2003
13. National Heart Foundation and Australian Institute of Health: Risk Factor Prevalence Study No. 3 1989. Canberra, Australia, National Heart Foundation and Australian Institute of Health, 1990
14. Best JD, Jerums G, Newnham HH, O'Brien RC: Diabetic dyslipidaemia: Australian Diabetes Society position statement. Med J Aust 162:91-93, 1995
15. NSW Health Department: The Principles of Diabetes Care and Guidelines for the Clinical Management of Diabetes Mellitus in Adults. Sydney, NSW Health Department, 1996
16. Diabetes Australia, Royal Australian College of General Practitioners (RACGP): Diabetes Management in General Practice, 5th Ed. Canberra, Australia, Diabetes Australia, 1998
17. Dyslipidemia management in adults with diabetes (Technical Review). Diabetes Care 27 (Suppl. 1):S68-S71, 2004
18. Hypertension management in adults with diabetes (Technical Review). Diabetes Care 27 (Suppl. 1):S65-S67, 2004
19. Standards of medical care in diabetes (Technical Review). Diabetes Care 27 (Suppl. 1):S15-S35, 2004